Decreased Acetyl-CoA–producing enzymes (ACLY) expression reduces tumor cell viability and inhibits tumor progression in glioblastoma, melanoma cancer, PDAC and prostate cancer [14, 15]. The gene discussed is ACLY; the disease is neoplasm.